JULIO MACHADO: Open Payments
NPI 1275579047 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 68 payments from 14 companies in 2025. Trend: 2023 $1,835 · 2024 $1,675 · 2025 $1,659
Food & beverage: $1,659
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 18 | $352 |
| Janssen Pharmaceuticals, Inc | 9 | $330 |
| ABBVIE INC. | 13 | $225 |
| Alkermes, Inc. | 9 | $197 |
| Teva Pharmaceuticals USA, Inc. | 1 | $118 |
| Axsome Therapeutics, Inc. | 4 | $108 |
| Vanda Pharmaceuticals Inc. | 4 | $103 |
| Neurocrine BioSciences, Inc. | 4 | $89 |
| Janssen Scientific Affairs, LLC | 1 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: COBENFY, INVEGA SUSTENNA, VRAYLAR, ARISTADA, AUSTEDO XR, Auvelity, FANAPT, INGREZZA.
Industry payments across FL — which companies pay providers there.
